Evidence map›Paper›PMID 35308479›Full record

ReviewClinical liver disease2022

Alcoholic Liver Disease.

Fátima Higuera-de-la-Tijera, Jorge Emilio Lira-Vera, Oscar Morales-Gutiérrez, Moisés Martínez-Castillo, Zaira Medina-Ávila, Alfredo Servín-Caamaño, José Luis Pérez-Hernández, Gabriela Gutiérrez-Reyes

Abstract readReview
In one paragraph

Review in Clinical liver disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. [Fibroblast growth factor 21 improves alcoholic liver disease by regulating gut microbiota in mice].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Article
  2. [Bioinformatics screening and analysis of key genes of ferroptosis and autophagy in alcoholic liver disease and their validation].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Seabuckthorn polysaccharide combined withFrontiers in endocrinology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fátima Higuera-de-la-TijeraGastroenterology and Hepatology Department Hospital General de México "Dr. Eduardo Liceaga," Mexico City Mexico.ORCID https://orcid.org/0000-0003-1862-7541
Jorge Emilio Lira-VeraGastroenterology and Hepatology Department Hospital General de México "Dr. Eduardo Liceaga," Mexico City Mexico.
Oscar Morales-GutiérrezGastroenterology and Hepatology Department Hospital General de México "Dr. Eduardo Liceaga," Mexico City Mexico.
Moisés Martínez-CastilloLiver, Pancreas and Motility Laboratory Department of Experimental Medicine Faculty of Medicine UNAM Mexico City Mexico.
Zaira Medina-ÁvilaLiver, Pancreas and Motility Laboratory Department of Experimental Medicine Faculty of Medicine UNAM Mexico City Mexico.
Alfredo Servín-CaamañoGastroenterology and Hepatology Department Hospital General de México "Dr. Eduardo Liceaga," Mexico City Mexico.
José Luis Pérez-HernándezGastroenterology and Hepatology Department Hospital General de México "Dr. Eduardo Liceaga," Mexico City Mexico.
Gabriela Gutiérrez-ReyesLiver, Pancreas and Motility Laboratory Department of Experimental Medicine Faculty of Medicine UNAM Mexico City Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Content available: Author Interview and Audio Recording.

Identifiers

PMID35308479
PMCPMC8912218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.